Why is Sanofi India falling/rising?

As of 19-Sep, Sanofi India Ltd is experiencing a decline in its stock price, currently at 5,038.65, reflecting a decrease of 5.3 points or 0.11%. The stock has underperformed its sector by 0.38% today and has been on a consecutive downward trend for the last two days, resulting in a total drop of 0.44%. Over the past week, Sanofi India has seen a return of -0.61%, and its performance over the last month and year has been similarly poor, with declines of 2.68% and 29.79%, respectively. The company is trading below all key moving averages, indicating a bearish trend. Despite high management efficiency and a low debt-to-equity ratio, the stock's valuation is considered premium compared to peers, and its profits have decreased by 9.4% over the past year, contributing to negative sentiment around the stock.
In the broader market context, while the Sensex has gained 0.88% over the past week, Sanofi India’s performance has lagged significantly, highlighting a stark contrast between the stock and the benchmark. The stock's long-term growth prospects appear poor, with net sales and operating profit declining over the last five years. Additionally, the company's recent quarterly results showed substantial declines in profit before tax and profit after tax compared to previous averages, further exacerbating investor concerns. Overall, the combination of underperformance relative to the market, declining financial metrics, and a premium valuation has led to a negative outlook for Sanofi India Ltd.